Atrium Therapeutics Inc (RNA)

Other Income/Expenses (Net)

$2.43M

Quarterly · Period ending: · USD

RNA logo

RNA Other Income/Expenses (Net)

Latest reported$2.43M
RNA Quarterly Other Income/Expenses (Net) ($0.00 → $2.43M)
High-resolution chart · PNG

RNA other income/expenses (net) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Atrium Therapeutics Inc Other Income/Expenses (Net) — Quarterly (USD)
Period endingOther Income/Expenses (Net) (USD)
2,432,000
647,000
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.